HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Si-Dong Xiong Selected Research

Synthetic Prostaglandins A

5/2014Disease association and arthritogenic potential of circulating antibodies against the α1,4-polygalacturonic acid moiety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Si-Dong Xiong Research Topics

Disease

6Infections
01/2018 - 11/2004
2Virus Diseases (Viral Diseases)
02/2016 - 03/2014
2Rheumatoid Arthritis
05/2014 - 01/2013
2Myocarditis (Carditis)
03/2009 - 11/2004
1Communicable Diseases (Infectious Diseases)
11/2021
1Inflammation (Inflammations)
02/2016
1Hyperplasia
05/2014
1Neoplasms (Cancer)
02/2014
1Acute-Phase Reaction
10/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
02/2016 - 10/2003
3Antiviral Agents (Antivirals)IBA
02/2016 - 01/2014
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2009 - 11/2004
1Volatile Oils (Essential Oils)IBA
11/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1RNA Polymerase II (RNA Polymerase B)IBA
01/2018
1Complement Factor B (Factor B)IBA
01/2018
1AutoantibodiesIBA
05/2014
1Synthetic Prostaglandins AIBA
05/2014
1Carrier Proteins (Binding Protein)IBA
05/2014
1Intercellular Adhesion Molecule-3IBA
03/2014
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
03/2014
1VaccinesIBA
03/2014
1Pathogen-Associated Molecular Pattern MoleculesIBA
02/2014
1EpitopesIBA
02/2014
1CarbohydratesIBA
02/2014
1GlucansIBA
02/2014
1MicroRNAs (MicroRNA)IBA
01/2014
1Phenobarbital (Luminal)FDA Link
01/2013
1CalreticulinIBA
01/2013
1ChemokinesIBA
03/2009
1Messenger RNA (mRNA)IBA
03/2009
1CCR2 ReceptorsIBA
11/2004

Therapy/Procedure

1Therapeutics
03/2014